Methods and agents for improving targeting of CD138 expressing tumor cells

Details for Australian Patent Application No. 2008339913 (hide)

Owner Biotest AG DANA-FARBER CANCER INSTITUTE, INC. ImmunoGen, Inc

Inventors Uherek, Christoph; Daelken, Benjamin; Bruecher, Christoph; Anderson, Kenneth; Hideshima, Teru

Agent Griffith Hack

Pub. Number AU-A-2008339913

PCT Pub. Number WO2009/080832

Priority 61/087,590 08.08.08 US; 61/016,614 26.12.07 US; 61/087,466 08.08.08 US

Filing date 23 December 2008

Wipo publication date 2 July 2009

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

15 July 2010 PCT application entered the National Phase

  PCT publication WO2009/080832 Priority application(s): WO2009/080832

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008339917-Macrocyclic indoles as hepatitis C virus inhibitors

2008339911-Immunoconjugates targeting CD138 and uses thereof